BPC-157, one of the compounds that was under review at the Food and Drug Administration's Pharmacy Compounding Advisory Committee hearing July 23-24, appears in preclinical studies to speed tissue repair and reduce inflammation
States have been using these programs to get the federal government to pay for services for which states should be responsible, the Trump administration said
Different involvement of promoter methylation in the expression of organic cation/carnitine transporter 2 (OCTN2) in cancer cell lines
As the bodys most powerful antioxidant, it flushes out toxins, fights off oxidative stress, neutralises free radicals and supports your immune system, too
Most published studies are limited to rodent models or cell cultures, leaving a gap in high-quality, peer-reviewed human clinical data